Published in Int J Clin Pract on February 01, 2007
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet (1995) 6.60
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol (1993) 4.16
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res (1995) 3.98
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res (1997) 3.37
How to run an induction meeting for house officers. BMJ (1992) 3.32
Terminology and classification of the cortical dysplasias. Neurology (2004) 2.99
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Inappropriate antihypertensive therapy in the elderly. Lancet (1976) 2.71
PMWS and porcine dermatitis nephropathy syndrome in Great Britain. Vet Rec (2000) 2.67
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A (2000) 2.47
Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol (1999) 2.45
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet (1991) 2.39
Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis (1983) 2.37
Extending animal models of fear conditioning to humans. Biol Psychol (2006) 2.31
Structure of the IgG-binding regions of streptococcal protein G. EMBO J (1986) 2.20
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res (1997) 2.14
The isolation of reovirus-like agents (rota-viruses) from acute gastroenteritis of piglets. J Med Microbiol (1976) 2.12
High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol (2001) 2.03
Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk. Int J Clin Pract (2010) 2.03
Factors associated with cardiac rehabilitation attendance: a systematic review of the literature. Clin Rehabil (2002) 1.94
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res (1993) 1.85
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol (2001) 1.80
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract (2009) 1.79
Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem (1984) 1.77
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet (2001) 1.76
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem (1990) 1.75
Uniformly spaced banding pattern in DNA sequencing gels by use of field-strength gradient. J Biochem Biophys Methods (1984) 1.71
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci U S A (1991) 1.69
Phosphorylation of Thr-948 at the C terminus of the plasma membrane H(+)-ATPase creates a binding site for the regulatory 14-3-3 protein. Plant Cell (1999) 1.67
Coronary artery disease and women. BMJ (1994) 1.65
Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology (2003) 1.65
Postmenopausal HRT--a role for tamoxifen? Int J Clin Pract (1998) 1.64
Why patients do not attend cardiac rehabilitation: role of intentions and illness beliefs. Heart (1999) 1.63
C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J (2000) 1.63
Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract (2013) 1.61
The 14-3-3 protein interacts directly with the C-terminal region of the plant plasma membrane H(+)-ATPase. Plant Cell (1997) 1.60
Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology (1999) 1.60
Strychnine poisoning treated successfully with diazepam. Br Med J (1971) 1.59
Intracardiac spread of intravenous leiomyomatosis with successful surgical excision. N Engl J Med (1980) 1.59
Faking it: the dangers of counterfeit medicine on the internet. Int J Clin Pract (2009) 1.58
Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev (1998) 1.58
A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology (1997) 1.56
The rise of post-traumatic stress disorders. BMJ (1991) 1.56
The story of the European Randomized Study of Screening for Prostate Cancer. BJU Int (2003) 1.55
Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb (1994) 1.52
Raised exercise diastolic blood pressure as indicator of ischaemic left ventricular dysfunction. Lancet (1991) 1.51
Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry (1975) 1.50
Postmenopausal hormone replacement therapy in hypertensive women: is it time for a change in attitude? J Hum Hypertens (1998) 1.50
Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clin Chem (1997) 1.50
Avoidable mortality in New Zealand, 1981-97. Aust N Z J Public Health (2001) 1.49
Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J (1994) 1.48
Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Münster study. J Hypertens (1998) 1.48
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J (1999) 1.48
Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation (1999) 1.48
Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J (2002) 1.47
Peripartum cardiomyopathy due to myocarditis. N Engl J Med (1982) 1.46
Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease. Digestion (2010) 1.45
Ventricular stroke work loss: validation of a method of quantifying the severity of aortic stenosis and derivation of an orifice formula. J Am Coll Cardiol (1990) 1.45
Solid phase DNA sequencing using the biotin-avidin system. Nucleic Acids Res (1988) 1.45
Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem (1983) 1.45
Interface between primary care and specialist mental health care. Br J Gen Pract (1992) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost (1998) 1.43
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem (2001) 1.43
Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation (1997) 1.43
Early exercise testing and coronary angiography after uncomplicated myocardial infarction. Br Med J (Clin Res Ed) (1982) 1.43
Unexplained breathlessness and psychiatric morbidity in patients with normal and abnormal coronary arteries. Lancet (1983) 1.43
Chelation therapy is TACT-less. Int J Clin Pract (2008) 1.42
JUPITER: wake up and smell the coffee--the absolute and relative merits of statin use. Int J Clin Pract (2009) 1.42
Possible linkage of Tourette syndrome to markers on short arm of chromosome 3 (C3p21-14) Lancet (1990) 1.42
Calcific degeneration of the aortic valve in old age: is the development of flow obstruction predictable? J Intern Med (1996) 1.41
Never mind the content, measure the impact: spin bowling for journal impact factors vs. the importance of patient impact. Int J Clin Pract (2010) 1.40
Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy. Clin Sci (Lond) (1998) 1.40
Resonant inelastic x-ray scattering at the oxygen K resonance of NiO: nonlocal charge transfer and double-singlet excitations. Phys Rev Lett (2006) 1.39
American journal owners 2, principled editors 0. Int J Clin Pract (2000) 1.39
Measurement of prostate-specific antigen: no advantage to ultrasensitive assays? J Natl Cancer Inst (1996) 1.39
The impact of the principles of evidence interpretation on the structure and content of statements. Sci Justice (2000) 1.39
[Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease]. Dtsch Med Wochenschr (2000) 1.39
Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood (1989) 1.39
Child abuse--a political, parental and religious syndrome. Int J Clin Pract (2000) 1.38
Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements. Br Med J (1975) 1.38
Testosterone reducing cardiovascular risk--looks promising but randomised trials needed. Int J Clin Pract (2008) 1.38
Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J Biol Chem (1995) 1.38
Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res (1996) 1.37
Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study. Eur Heart J (1997) 1.37
Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart (2003) 1.36
Assessment of left atrial volumes and phasic function using cine magnetic resonance imaging in normal subjects. Am J Cardiol (1994) 1.36
The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells. Nucleic Acids Res (1988) 1.35
Non-atherosclerotic coronary artery aneurysms: two case reports. Heart (1997) 1.34
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol (1999) 1.34
Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem (1988) 1.33
Hind III RFLP in the lipoprotein lipase gene, (LPL). Nucleic Acids Res (1987) 1.32
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J Biol Chem (1990) 1.31
Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. Br Med J (1975) 1.29
Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood (1998) 1.29